Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Prepaid Assets (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Prepaid Assets over the past 15 years, most recently at $1.5 million for Q2 2025.

  • For Q2 2025, Prepaid Assets rose 1.04% year-over-year to $1.5 million; the TTM value through May 2025 reached $1.5 million, up 1.04%, while the annual FY2025 figure was $1.5 million, 1.04% up from the prior year.
  • Prepaid Assets for Q2 2025 was $1.5 million at Lifecore Biomedical, Inc. \De\, down from $2.5 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $5.9 million in Q1 2021 and troughed at $1.3 million in Q3 2021.
  • A 5-year average of $2.4 million and a median of $1.9 million in 2023 define the central range for Prepaid Assets.
  • Biggest five-year swings in Prepaid Assets: tumbled 90.5% in 2021 and later skyrocketed 195.32% in 2023.
  • Year by year, Prepaid Assets stood at $1.4 million in 2021, then grew by 16.1% to $1.7 million in 2022, then grew by 10.28% to $1.8 million in 2023, then soared by 56.42% to $2.9 million in 2024, then tumbled by 49.62% to $1.5 million in 2025.
  • Business Quant data shows Prepaid Assets for LFCR at $1.5 million in Q2 2025, $2.5 million in Q1 2025, and $2.9 million in Q4 2024.